Epi Lovastatin Hydroxy Acid Sodium Salt CAS 101400-30-0
| CAS No. | 101400-30-0 |
| Molecular Formula | C24H38O6 |
| Molecular Weight | N/A |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Epi Lovastatin Hydroxy Acid Sodium Salt (CAS 101400-30-0) is a high-purity analytical reference standard with the molecular formula C24H38O6Na and a molecular weight of 445.55 g/mol.
The molecular framework of Epi Lovastatin Hydroxy Acid Sodium Salt (C24H38O6Na) is characterized by a steroid core, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the polarity and ionization state of its functional groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C24H38O6 Na |
| Molecular Weight | 445.55 g/mol |
| Appearance | Off-white to pale yellow crystalline powder |
| Purity | 97%+ |
| Storage | Store at room temperature, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO, water (slightly soluble) |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 6.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1985 |
Related Epi Standards
- Lovastatin-d3 (CAS 1002345-93-8)
- Lovastatin EP Impurity F (CAS 1048973-04-1)
- Lovastatin Impurity N1 (CAS 106909-04-0)
- Lovastatin EP Impurity C (CAS 109273-98-5)
- Lovastatin Acid Triol Sodium Salt (CAS 132294-94-1)
- Lovastatin EP Impurity D (Lovastatin Dimer) (CAS 149756-62-7)
- Lovastatin Anhydro Acid Sodium Salt (CAS 188067-71-2)
- Lovastatin EP Impurity A (CAS 73573-88-3)
Recommended Standards
- 2-Methoxy-4-(trifluoromethyl)nicotinaldehyde (CAS 1227594-83-3)
- 3-(3-Fluorophenyl)-5-(trifluoromethyl)picolinic acid (CAS 1214376-43-8)
- 4-Amino-2-(difluoromethyl)-5-methylpyridin-3-ol (CAS 1805080-12-9)
- 2-methyl-3-oxo-2H,3H,5H,6H,7H,8H-imidazo[1,5-a]pyridine-1-carboxylic acid (CAS 1820641-84-6)
- Deruxtecan Impurity 8 (CAS CATO-C4X-30578)
- 3-(Isothiazol-5-yl)aniline (CAS 904086-00-6)
- 2-(pyrrolidin-2-yl)-4-[3-(trifluoromethyl)phenyl]-1H-imidazole dihydrochloride (CAS 1315366-83-6)
- Ixazomib Impurity 53 (CAS CATO-C4X-126753)
- 5-(Ethylsulfonyl)-N-methyl-1,3,4-thiadiazol-2-amine (CAS 72836-35-2)
- Insulin degludec (CAS 844439-96-9)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com